biomarker signatures | Biomarker Commons

biomarker signatures

Genome Institute of Singapore and Sengenics Enter Into Partnership for Early Detection of Cancer Cells

The Genome Institute of Singapore (GIS) of the Agency for Science, Technology and Research (A*STAR), and Sengenics recently announced a partnership for cancer biomarker discovery with the aim to identify and validate auto-antibodies that can be used to detect early-stage cancers.


Premium Subscription Required for Access


Premium Subscription Required for Access


Premium Subscription Required for Access


Premium Subscription Required for Access


Premium Subscription Required for Access